Higher cerebrospinal fluid (CSF) opening pressure in patients with idiopatic intracranial hypertension (IIH) with permanent visual impairment

Autores

DOI:

https://doi.org/10.48208/HeadacheMed.2022.22

Palavras-chave:

Cefaleia, hipertensão intracraniana idiopática (HII), líquido cefalorraqueano (LCR), ressonância magnética (RM), obesidade

Resumo

OBJETIVO: O objetivo deste estudo foi identificar potenciais marcadores prognósticos visuais em pacientes com hipertensão intracraniana idiopática (HII).

MÉTODOS: Pacientes com HII de um ambulatório de cefaleia em São Paulo, Brasil, foram avaliados retrospectivamente e divididos em dois grupos de acordo com a presença ou não de redução visual permanente atribuída a HII. O índice de massa corporal (IMC), a pressão de abertura do LCR e a frequência de anormalidades de RM relacionadas à HII foram comparados entre esses dois grupos.

RESULTADOS: Vinte e nove pacientes, com 35,39±9,93 anos, sendo vinte e oito do sexo feminino (96,55%), foram incluídos no estudo. A redução da acuidade visual atribuída à HII foi registrada em 16 (55,17%). De acordo com o IMC, 17,4% tinham sobrepeso e 82,6% eram obesos. A ressonância magnética cerebral foi normal em 6 (20,69%). O IMC, a frequência de obesidade e a frequência de anormalidades na RM relacionadas à HII não foram associados à deficiência visual. A pressão inicial de abertura do LCR inicial foi significativamente maior no grupo de pacientes com acuidade visual reduzida (40,4±13,14 x 30,5±3,41, P=0,015).

CONCLUSÃO: Os pacientes com deficiência visual permanente associada à HII tiveram maior pressão de abertura do LCR, sugerindo que esse parâmetro tenha potencial valor para a avaliação prognóstica destes pacientes.

Downloads

Não há dados estatísticos.

Referências

Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013 Sep 24;81(13):1159-65. doi: 10.1212/WNL.0b013e3182a55f17. Epub 2013 Aug 21. PMID: 23966248. DOI: https://doi.org/10.1212/WNL.0b013e3182a55f17

Toscano S, Lo Fermo S, Reggio E, Chisari CG, Patti F, Zappia M. An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management. J Neurol. 2021 Sep;268(9):3249-3268. doi: 10.1007/s00415-020-09943-9. Epub 2020 May 27. PMID: 32462350. DOI: https://doi.org/10.1007/s00415-020-09943-9

Wall M. Update on Idiopathic Intracranial Hypertension. Neurol Clin. 2017 Feb;35(1):45-57. doi: 10.1016/j.ncl.2016.08.004. PMID: 27886895; PMCID: PMC5125521. DOI: https://doi.org/10.1016/j.ncl.2016.08.004

Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021 Feb 1;34(1):75-83. doi: 10.1097/WCO.0000000000000885. PMID: 33230036; PMCID: PMC7856277. DOI: https://doi.org/10.1097/WCO.0000000000000885

Chagot C, Blonski M, Machu JL, Bracard S, Lacour JC, Richard S. Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management. J Obes. 2017;2017:5348928. doi: 10.1155/2017/5348928. Epub 2017 Aug 13. PMID: 28884026; PMCID: PMC5572623. DOI: https://doi.org/10.1155/2017/5348928

Kaya FS, Bayram E, İnci E. Evaluating the optic nerve stiffness and optic nerve sheath diameter in idiopathic intracranial hypertension patients after the resolution of papilledema. Neurol Sci. 2021 Dec;42(12):5165-5170. doi: 10.1007/s10072-021-05208-z. Epub 2021 Mar 31. PMID: 33788047. DOI: https://doi.org/10.1007/s10072-021-05208-z

Afonso CL, Talans A, Monteiro ML. Factors affecting visual loss and visual recovery in patients with pseudotumor cerebri syndrome. Arq Bras Oftalmol. 2015 May-Jun;78(3):175-9. doi: 10.5935/0004-2749.20150045. PMID: 26222108. DOI: https://doi.org/10.5935/0004-2749.20150045

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. PMID: 29368949. DOI: https://doi.org/10.1177/0333102417738202

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. PMID: 24756514; PMCID: PMC4362615. DOI: https://doi.org/10.1001/jama.2014.3312

Friedman DI. Contemporary management of the pseudotumor cerebri syndrome. Expert Rev Neurother. 2019 Sep;19(9):881-893. doi: 10.1080/14737175.2019.1660163. Epub 2019 Sep 17. PMID: 31478394. DOI: https://doi.org/10.1080/14737175.2019.1660163

Kaufman DI, Friedman DI. Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension? J Neuroophthalmol. 2017 Jun;37(2):182-186. doi: 10.1097/WNO.0000000000000513. PMID: 28376023. DOI: https://doi.org/10.1097/WNO.0000000000000513

Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M, Kardon RH. Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension. Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3850-9. doi: 10.1167/iovs.15-16450. PMID: 26070058; PMCID: PMC4697859. DOI: https://doi.org/10.1167/iovs.15-16450

Hoffmann J, Kreutz KM, Csapó-Schmidt C, Becker N, Kunte H, Fekonja LS, Jadan A, Wiener E. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain. 2019 May 23;20(1):59. doi: 10.1186/s10194-019-1004-1. PMID: 31122204; PMCID: PMC6734439. DOI: https://doi.org/10.1186/s10194-019-1004-1

Reier L, Fowler JB, Arshad M, Hadi H, Whitney E, Farmah AV, Siddiqi J. Optic Disc Edema and Elevated Intracranial Pressure (ICP): A Comprehensive Review of Papilledema. Cureus. 2022 May 11;14(5):e24915. doi: 10.7759/cureus.24915. PMID: 35698673; PMCID: PMC9187153. DOI: https://doi.org/10.7759/cureus.24915

Szewka AJ, Bruce BB, Newman NJ, Biousse V. Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol. 2013 Mar;33(1):4-8. doi: 10.1097/WNO.0b013e31823f852d. PMID: 22217456; PMCID: PMC3323689. DOI: https://doi.org/10.1097/WNO.0b013e31823f852d

Baldwin MK, Lobb B, Tanne E, Egan R. Weight and visual field deficits in women with idiopathic intracranial hypertension. J Womens Health (Larchmt). 2010 Oct;19(10):1893-8. doi: 10.1089/jwh.2009.1804. PMID: 20849287. DOI: https://doi.org/10.1089/jwh.2009.1804

Brazis PW. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension. Am J Ophthalmol. 2007 Apr;143(4):683-4. doi: 10.1016/j.ajo.2007.01.001. PMID: 17386277. DOI: https://doi.org/10.1016/j.ajo.2007.01.001

Bø SH, Lundqvist C. Cerebrospinal fluid opening pressure in clinical practice - a prospective study. J Neurol. 2020 Dec;267(12):3696-3701. doi: 10.1007/s00415-020-10075-3. Epub 2020 Jul 17. PMID: 32681283; PMCID: PMC7674322. DOI: https://doi.org/10.1007/s00415-020-10075-3

Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991 Feb;114 ( Pt 1A):155-80. PMID: 1998880.

Eshtiaghi A, Zaslavsky K, Nicholson P, Margolin E. Extent of transverse sinus stenosis does not predict visual outcomes in idiopathic intracranial hypertension. Eye (Lond). 2022 Jul;36(7):1390-1395. doi: 10.1038/s41433-021-01651-6. Epub 2021 Jun 28. PMID: 34183795; PMCID: PMC9232644. DOI: https://doi.org/10.1038/s41433-021-01651-6

Saindane AM, Bruce BB, Riggeal BD, Newman NJ, Biousse V. Association of MRI findings and visual outcome in idiopathic intracranial hypertension. AJR Am J Roentgenol. 2013 Aug;201(2):412-8. doi: 10.2214/AJR.12.9638. PMID: 23883223; PMCID: PMC4048553. DOI: https://doi.org/10.2214/AJR.12.9638

Batur Caglayan HZ, Ucar M, Hasanreisoglu M, Nazliel B, Tokgoz N. Magnetic Resonance Imaging of Idiopathic Intracranial Hypertension: Before and After Treatment. J Neuroophthalmol. 2019 Sep;39(3):324-329. doi: 10.1097/WNO.0000000000000792. PMID: 31430269. DOI: https://doi.org/10.1097/WNO.0000000000000792

Moreno-Ajona D, McHugh JA, Hoffmann J. An Update on Imaging in Idiopathic Intracranial Hypertension. Front Neurol. 2020 Jun 10;11:453. doi: 10.3389/fneur.2020.00453. PMID: 32587565; PMCID: PMC7297913. DOI: https://doi.org/10.3389/fneur.2020.00453

Juhász J, Hensler J, Jansen O. MRI-findings in idiopathic intracranial hypertension (Pseudotumor cerebri). Rofo. 2021 Nov;193(11):1269-1276. English, German. doi: 10.1055/a-1447-0264. Epub 2021 May 12. PMID: 33979869. DOI: https://doi.org/10.1055/a-1447-0264

Downloads

Publicado

2022-10-01

Como Citar

1.
Domingues R, Senne C, Lacerda CB. Higher cerebrospinal fluid (CSF) opening pressure in patients with idiopatic intracranial hypertension (IIH) with permanent visual impairment. Headache Med [Internet]. 1º de outubro de 2022 [citado 21º de novembro de 2024];13(3):208-12. Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/651

Edição

Seção

Original

Artigos mais lidos pelo mesmo(s) autor(es)